Hiperfosfatemia                                                                             Hyperphosphatemia  

Wu HC, et al. Associations among time-average mineral values, mortality and cardiovascular events in hemodialysis patients. Ren Fail. 2015; 37(10):343-53.

Tsai WC, et al. Additional benefit of dietitian involvement in dialysis staffs-led diet education on uncontrolled hyperphosphatemia in hemodialysis patients. Clin Exp Nephrol. 2015 Dec 11.

Umeukeje EM, et al. Self-Motivation Is Associated With Phosphorus Control in End-Stage Renal Disease. J Ren Nutr. 2015; 25(5):433-9.

Shi Y, et a. Educational intervention for metabolic bone disease in patients with chronic kidney disease: a systematic review and meta-analysis. J Ren Nutr. 2014; 24(6):371-84.

Shi YX, et al. Effectiveness of a nurse-led intensive educational programme on chronic kidney failure patients with

hyperphosphataemia: randomised controlled trial. J Clin Nurs. 2013; 22(7-8):1189-97.

Sandlin K, et al. The impact of nurse-led education on haemodialysis patients’ phosphate binder medication adherence. J Ren Care. 2013;39(1):12-8.

Karavetian M, Ghaddar S. Nutritional education for the management of osteodystrophy (nemo) in patients on haemodialysis: a randomised controlled trial. J Ren Care. 2013; 39(1):19-30.

Crawford A, Harris H. Balancing act: calcium & phosphorus. Nursing. 2012; 42(1):36-42.

Wang LM, Hung SY, Chiou CP. Behavior modification therapy: application in renal nursing. Hu Li Za Zhi. 2011 58(2):10-5.

Xing XS, Yamaguchi DT, Weintraub NT. A synopsis of phosphate disorders in the nursing home. J Am Med Dir Assoc. 2010 11(7):468-74.

Khalil AA, Frazier SK. Depressive symptoms and dietary nonadherence in patients with end-stage renal disease receiving hemodialysis: a review of quantitative evidence. Issues Ment Health Nurs. 2010 31(5):324-30.

St Peter WL, Fan Q, Weinhandl E, Liu J. Economic evaluation of sevelamer versus calcium-based phosphate binders in hemodialysis patients: a secondary analysis using centers for Medicare & Medicaid services data. Clin J Am Soc Nephrol. 2009 4(12):1954-61.

Beto JA, Nicholas M. So just what can I eat? Nutritional care in patients with diabetes mellitus and chronic kidney disease. Nephrol Nurs J. 2009 36(5):497-504.

Yamana E. The relationship of clinical laboratory parameters and patient attributes to the quality of life of patients on hemodialysis. Jpn J Nurs Sci.2009 6(1):9-20.

Zimmerman DR, Goldstein L, Lahat E, Braunstein R, Stahi D, Bar-Haim A, Berkovitch M. Effect of a 24+ hour fast on breast milk composition. J Hum Lact. 2009 25(2):194-8.

Elseviers M, De Vos JY. The use of phosphate binders: data from contributors to the European Practice Database. J Ren Care. 2009 35 Suppl 1:14-8.

Lee H, Kim M, Daly BJ. Nutritional patterns of Korean diabetic patients: an exploratory study. Int Nurs Rev. 2008 55(4):442-6.

Carver M, Carder J, Hartwell L, Arjomand M. Management of mineral and bone disorders in patients on dialysis: a team approach to improving outcomes. Nephrol Nurs J. 2008 35(3):265-70.

King JE. What is tumor lysis syndrome? Nursing. 2008 38(5):18.

McCarley PB, Arjomand M. Mineral and bone disorders in patients on dialysis: physiology and clinical consequences. Nephrol Nurs J. 2008 35(1):59-64.

Owen P, Monahan MF, MacLaren R. Implementing and assessing an evidence-based electrolyte dosing order form in the medical ICU. Intensive Crit Care Nurs. 2008 24(1):8-19.

Dowell SA, Welch JL. Use of electronic self-monitoring for food and fluid intake: A pilot study. Nephrol Nurs J. 2006  33(3):271-7.

Haut C. Oncological emergencies in the pediatric intensive care unit. AACN Clin Issues. 2005 16(2):232-45.

Yucha C, Dungan J. Renal handling of phosphorus and magnesium. Nephrol Nurs J. 2004 31(1):33-7.

Kaplow R. Pathophysiology, signs, and symptoms of acute tumor lysis syndrome. Semin Oncol Nurs. 2002 18(3 Suppl 3):6-11.

Truini-Pittman L, Rossetto C. Pediatric considerations in tumor lysis syndrome. Semin Oncol Nurs. 2002 18(3 Suppl 3):17-22.

Gobel BH. Management of tumor lysis syndrome: prevention and treatment. Semin Oncol Nurs. 2002 18(3 Suppl 3):12-6.

Vlaminck H, Maes B, Jacobs A, Reyntjens S, Evers G. The dialysis diet and fluid non-adherence questionnaire: validity testing of a self-report instrument for clinical practice. J Clin Nurs. 2001 10(5):707-15.

Janigan DT, Perey B, Marrie TJ, Chiasson PM, Hirsch D. Skin necrosis: an unusual complication of hyperphosphatemia during total parenteral nutrition therapy. JPEN J Parenter Enteral Nutr. 1997 21(1):50-2. 

 

Riesgo de hiperfosfatemia                                                             Risk of hyperphosphatemia  

Umeukeje EM, et al. Self-Motivation Is Associated With Phosphorus Control in End-Stage Renal Disease. J Ren Nutr. 2015; 25(5):433-9.

Shi Y, et a. Educational intervention for metabolic bone disease in patients with chronic kidney disease: a systematic review and meta-analysis. J Ren Nutr. 2014; 24(6):371-84.

Sandlin K, et al. The impact of nurse-led education on haemodialysis patients’ phosphate binder medication adherence. J Ren Care. 2013;39(1):12-8.

Jamal SA, Vet al. Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet. 2013;382(9900):1268-77.

Crawford A, Harris H. Balancing act: calcium & phosphorus. Nursing. 2012; 42(1):36-42.

Wang LM, Hung SY, Chiou CP. Behavior modification therapy: application in renal nursing. Hu Li Za Zhi. 2011 58(2):10-5.

Khalil AA, Frazier SK. Depressive symptoms and dietary nonadherence in patients with end-stage renal disease receiving hemodialysis: a review of quantitative evidence. Issues Ment Health Nurs. 2010 31(5):324-30.

Beto JA, Nicholas M. So just what can I eat? Nutritional care in patients with diabetes mellitus and chronic kidney disease. Nephrol Nurs J. 2009 36(5):497-504.

Yamana E. The relationship of clinical laboratory parameters and patient attributes to the quality of life of patients on hemodialysis. Jpn J Nurs Sci.2009 6(1):9-20.

Zimmerman DR, Goldstein L, Lahat E, Braunstein R, Stahi D, Bar-Haim A, Berkovitch M. Effect of a 24+ hour fast on breast milk composition. J Hum Lact. 2009 25(2):194-8.

Elseviers M, De Vos JY. The use of phosphate binders: data from contributors to the European Practice Database. J Ren Care. 2009 35 Suppl 1:14-8.

Lee H, Kim M, Daly BJ. Nutritional patterns of Korean diabetic patients: an exploratory study. Int Nurs Rev. 2008 55(4):442-6.

McCarley PB, Arjomand M. Mineral and bone disorders in patients on dialysis: physiology and clinical consequences. Nephrol Nurs J. 2008 35(1):59-64.

Dowell SA, Welch JL. Use of electronic self-monitoring for food and fluid intake: A pilot study. Nephrol Nurs J. 2006  33(3):271-7.

Yucha C, Dungan J. Renal handling of phosphorus and magnesium. Nephrol Nurs J. 2004 31(1):33-7.

 

Hipofosfatemia                                                                           Hypophosphatemia  

Chen LJ, et al. Refeeding syndrome in Southeastern Taiwan: our experience with 11 cases. World J Gastroenterol. 2014; 20(30):10525-30.

Chang JF, et al. Combined alkaline phosphatase and phosphorus levels as a predictor of mortality in maintenance hemodialysis patients. Medicine (Baltimore). 2014; 93(18):e106.

Crawford A, Harris H. Balancing act: calcium & phosphorus. Nursing. 2012;42(1):36-42.

Xing XS, Yamaguchi DT, Weintraub NT. A synopsis of phosphate disorders in the nursing home. J Am Med Dir Assoc. 2010 11(7):468-74.

Kanji Z, Jung K. Evaluation of an electrolyte replacement protocol in an adult intensive care unit: a retrospective before and after analysis. Intensive Crit Care Nurs. 2009 25(4):181-9.

Adkins SM. Recognizing and preventing refeeding syndrome. Dimens Crit Care Nurs. 2009 28(2):53-8.

Malizzia LJ, Hsu A. Temsirolimus, an mTOR inhibitor for treatment of patients with advanced renal cell carcinoma. Clin J Oncol Nurs. 2008 12(4):639-46.

Bevacqua JE. Diabetic ketoacidosis in the pediatric ICU. Crit Care Nurs Clin North Am. 2005 17(4):341-7.

De Manicor NA. Primary hyperparathyroidism: a case study. J Perianesth Nurs. 2004 19(5):334-41.

Ladage E. Refeeding syndrome. ORL Head Neck Nurs. 2003 21(3):18-20.

 

Riesgo de hiperfosfatemia                                                             Risk of hyperphosphatemia  

Crawford A, Harris H. Balancing act: calcium & phosphorus. Nursing. 2012;42(1):36-42.

Liamis G, et al. Medication-induced hypophosphatemia: a review. QJM. 2010 Jul;103(7):449-59.

Xing XS, Yamaguchi DT, Weintraub NT. A synopsis of phosphate disorders in the nursing home. J Am Med Dir Assoc. 2010; 11(7):468-74.

Kanji Z, Jung K. Evaluation of an electrolyte replacement protocol in an adult intensive care unit: a retrospective before and after analysis. Intensive Crit Care Nurs. 2009; 25(4):181-9.

Adkins SM. Recognizing and preventing refeeding syndrome. Dimens Crit Care Nurs. 2009; 28(2):53-8.

Malizzia LJ, Hsu A. Temsirolimus, an mTOR inhibitor for treatment of patients with advanced renal cell carcinoma. Clin J Oncol Nurs. 2008 12(4):639-46.

Lauts NM. Management of the patient with refeeding syndrome. J Infus Nurs. 2005; 28(5):337-42.

Bevacqua JE. Diabetic ketoacidosis in the pediatric ICU. Crit Care Nurs Clin North Am. 2005 17(4):341-7.

De Manicor NA. Primary hyperparathyroidism: a case study. J Perianesth Nurs. 2004 19(5):334-41.

Gardner VA, et al. A case study utilizing an enteral refeeding technique in a premature infant with short bowel syndrome. Adv Neonatal Care. 2003; 3(6):258-68.

Ladage E. Refeeding syndrome. ORL Head Neck Nurs. 2003; 21(3):18-20.

 

Agar JW, et al, Boddington JM, Waldron CM. Nocturnal hemodialysis in Australia. Hemodial Int. 2003; 7(4):278-89.

 

Versión para imprimir Versión para imprimir | Mapa del sitio
© NAAXPOT SLU © ATIC